TD Ameritrade Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-74
| Closed | -$7K | – | 313 |
|
|
2023
Q2 | $7K | Sell |
74
-33
| -31% | -$3.12K | ﹤0.01% | 380 |
|
|
2023
Q1 | $11K | Sell |
107
-43
| -29% | -$4.42K | ﹤0.01% | 368 |
|
|
2022
Q4 | $18K | Buy |
+150
| New | +$18K | ﹤0.01% | 332 |
|
|
2022
Q3 | – | Sell |
-305
| Closed | -$30K | – | 625 |
|
|
2022
Q2 | $30K | Sell |
305
-189
| -38% | -$18.6K | ﹤0.01% | 344 |
|
|
2022
Q1 | $46K | Sell |
494
-38
| -7% | -$3.54K | ﹤0.01% | 362 |
|
|
2021
Q4 | $45K | Buy |
+532
| New | +$45K | ﹤0.01% | 358 |
|